Clinical Trials

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms

NCT00499291 2023-05-25

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Phase NA Withdrawn

Teratoma, Testicular, Teratoma, Ovarian, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Teratoma, Testicular Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma

NCT01407770 2023-03-28

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer

1,000 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Depression, Fatigue, Pain, Radiation Injuries, Skin Abnormalities

NCT00436566 2022-08-05

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Phase 2 Completed

122 enrolled 22 charts

Breast Neoplasms, Breast Neoplasms, Male, Cardiotoxicity

NCT00918892 2022-08-01

Assessment of Candidate Protein Expression in Breast Cancer Specimens

460 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03521245 2021-09-14

Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

40 enrolled

Breast Neoplasms

NCT00896727 2019-12-20

S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313

2,100 enrolled

Breast Neoplasms

NCT01153672 2019-09-06

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy

8 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01562288 2019-07-02

Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab

1,576 enrolled

Breast Neoplasms

NCT00991263 2017-08-08

Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741

3,677 enrolled

Breast Neoplasms

NCT00764322 2017-08-01

NRR

Phase 2 Completed

501 enrolled 14 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00899197 2017-08-01

Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Terminated

2 enrolled

Breast Neoplasms

NCT01132560 2017-05-17

Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ

500 enrolled

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01156168 2017-05-17

Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab

363 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT01293032 2016-07-12

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

59 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00898573 2015-10-02

Lapatinib Resistance in Patients With Breast Cancer

Withdrawn

Breast Neoplasms

NCT01420185 2015-05-08

Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

1,300 enrolled

Breast Neoplasms

NCT00081003 2014-07-23

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy in Screening Women at Moderate-to-High Risk of Developing Breast Cancer

1,000 enrolled

Breast Neoplasms

NCT00544804 2014-07-02

Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

Phase 1 Completed

41 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01138345 2014-02-27

Biomarkers in Blood Samples From Older Breast Cancer Survivors

246 enrolled

Breast Neoplasms

NCT00898690 2013-12-18

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

120 enrolled

BreastGenitourinaryGynecologicSarcoma

Breast Neoplasms

NCT00601406 2013-08-26

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Phase NA Unknown

2,200 enrolled

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Breast Neoplasms, Male

NCT00691509 2013-08-26

Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer

2,300 enrolled

Breast Neoplasms

NCT00899418 2013-04-04

Studying Tumor Tissue Samples to Learn More About DNA Changes and Response in Patients With Breast Cancer Treated With Bevacizumab on Clinical Trial ECOG-2100

500 enrolled

Breast Neoplasms

NCT00914043 2013-01-11

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

Withdrawn

Breast Neoplasms, Fatigue

NCT00900406 2012-11-06

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

190 enrolled

Testicular Germ Cell Tumor, Breast Neoplasms, Graft vs Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Gestational Trophoblastic Disease, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

NCT00870168 2011-05-16

Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer

60 enrolled